Midatech Pharma plc
MTP · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $83 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $1,665 | $3,248 | $2,189 | $2,251 |
| Gross Profit | -$1,665 | -$3,248 | -$2,189 | -$2,168 |
| % Margin | – | – | – | -2,612% |
| R&D Expenses | $1,665 | $3,248 | $2,189 | $1,816 |
| G&A Expenses | $2,378 | $1,759 | $2,034 | $741 |
| SG&A Expenses | $2,378 | $1,759 | $2,034 | $741 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,692 | -$3,279 | $0 | -$955 |
| Operating Expenses | $2,351 | $1,728 | $4,223 | $1,602 |
| Operating Income | -$4,016 | -$4,976 | -$4,223 | -$3,770 |
| % Margin | – | – | – | -4,542.2% |
| Other Income/Exp. Net | $45 | $2,430 | $790 | $141 |
| Pre-Tax Income | -$3,971 | -$2,546 | -$3,433 | -$3,629 |
| Tax Expense | $165 | -$125 | -$125 | -$118 |
| Net Income | -$3,806 | -$2,421 | -$3,308 | -$3,511 |
| % Margin | – | – | – | -4,230.1% |
| EPS | -15.06 | -3.65 | -7.92 | -1.13 |
| % Growth | -312.6% | 53.9% | -600.9% | – |
| EPS Diluted | -15.06 | -3.65 | -7.92 | -1.13 |
| Weighted Avg Shares Out | 253 | 6,195,231 | 247,809 | 3,098 |
| Weighted Avg Shares Out Dil | 253 | 6,195,231 | 247,809 | 3,098 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $88 | $40 |
| Interest Expense | $100 | $37 | $49 | $0 |
| Depreciation & Amortization | $71 | $49 | $136 | $73 |
| EBITDA | -$3,945 | -$4,927 | -$3,248 | -$2,287 |
| % Margin | – | – | – | -2,755.4% |